drshieldsmd Profile Banner
Misty Dawn Shields Profile
Misty Dawn Shields

@drshieldsmd

Followers
2K
Following
21K
Media
261
Statuses
1K

Translational Thoracic Oncologist #MDPhD, #SCLC, @TheShieldsLab, Indiana University, HHMI Med Into Grad Scholar/IASLC ILCF/ASCO CDA, founder @SCLCSMASHERS 🫁🤍

Indianapolis, IN
Joined September 2013
Don't wanna be here? Send us removal request.
@drshieldsmd
Misty Dawn Shields
3 years
Always incredible to catch up with my lifelong mentor, hero, and friend, Dr. John Minna. @iaslungcancer #sclc23 #lcsm #mentorship #lungcancerresearch
5
1
98
@OncBrothers
Oncology Brothers
7 days
ToxCheck: AEs for ADCs approved in Lung Cancer & how to manage them with @sands_jacob: ✅ TDXd: HER2+ ✅ DatoDXd: EGFR+ ✅ TelisoV: C-MET Full 🗣️: ⭐️ https://t.co/qG1al4sR1b ⭐️ Also on “Oncology Brothers” podcast #OncTwitter @OncUpdates @OncoAlert #lcsm
2
10
29
@lungoncdoc
Eric K. Singhi, MD
7 days
Important results from our BREATHE study. Unique thoracic oncology pressures: 📈 Rapidly evolving treatments, late diagnoses, high mortality & patient volume all fuel burnout. 📊 62% keep up with emerging data regularly, yet 30+% struggle to keep pace. More to come.
@Lung_Cancers
Lung Cancers Today
7 days
🗨️ What did the BREATHE study show about burnout & resilience in early-career thoracic oncologists? ⭐ Don't miss this interview with @lungoncdoc, who shares insights on the data presented at #NACLC25! ➡️ Watch now: https://t.co/ojRIQ8As1S #lcsm #LungCancer
3
5
14
@lungoncdoc
Eric K. Singhi, MD
14 days
Proud mentor moment! Our team’s single-institution study on young-onset lung cancer was presented at #NACLC25. Grateful for these incredible colleagues who share a commitment to advancing care for this pt population. More to come, stay tuned! @MDAndersonNews @maraantonoff
0
2
31
@ConquerCancerFd
Conquer Cancer, the ASCO Foundation
15 days
Your support has helped make 2025 a year to remember. We're incredibly grateful for all that you do to support cancer research and care through Conquer Cancer. Please help us by sharing this impact with others. #2025Wrapped #ResearchConquersCancer
0
5
11
@lungoncdoc
Eric K. Singhi, MD
14 days
Our BREATHE study highlights unique thoracic oncology pressures: 📈 Rapidly evolving treatments, late diagnoses, high mortality & patient volume all fuel burnout. 📊 62% keep up with emerging data regularly, yet 30+% struggle to keep pace. Grateful to our study team. #NACLC25
@lungoncdoc
Eric K. Singhi, MD
14 days
So proud of @ASridharMD sharing results from our BREATHE study: the first to characterize burnout in early-career thoracic oncologists. 🔥 >1 in 3 early-career oncologists affected 💡 Marriage, sleep & family responsibility appear to be protective @IASLC #NACLC25
2
5
25
@ASridharMD
Arthi Sridhar
14 days
This morning we presented some results from the BREATHE study ➡️35% of respondants experienced severe burnout by MBI ➡️ close to 50% had self reported symptoms of burnout ➡️ Over 80% still had a high sense of personal accomplishment @lungoncdoc @drshieldsmd @ipreeshagul
@lungoncdoc
Eric K. Singhi, MD
14 days
So proud of @ASridharMD sharing results from our BREATHE study: the first to characterize burnout in early-career thoracic oncologists. 🔥 >1 in 3 early-career oncologists affected 💡 Marriage, sleep & family responsibility appear to be protective @IASLC #NACLC25
0
3
14
@lungoncdoc
Eric K. Singhi, MD
14 days
So proud of @ASridharMD sharing results from our BREATHE study: the first to characterize burnout in early-career thoracic oncologists. 🔥 >1 in 3 early-career oncologists affected 💡 Marriage, sleep & family responsibility appear to be protective @IASLC #NACLC25
2
4
21
@drshieldsmd
Misty Dawn Shields
15 days
Thank you @gotoPER for providing resources for high impact #CME in an ever-changing landscape for treatment of #SCLC. @ErminiaMassare1 @SclcSMASHERS @LUNGevity @LungCancerRx #LCSM
@gotoPER
PER
16 days
🫁New free #SCLC CME activity available now, on-demand! Hear from @ErminiaMassare1 & @drshieldsmd on novel treatment approaches, AE prevention strategies, and best practices for managing patients in the second- and subsequent-line setting. 🔗 https://t.co/plnHfJTGFK #lungcancer
0
1
11
@gotoPER
PER
16 days
🫁New free #SCLC CME activity available now, on-demand! Hear from @ErminiaMassare1 & @drshieldsmd on novel treatment approaches, AE prevention strategies, and best practices for managing patients in the second- and subsequent-line setting. 🔗 https://t.co/plnHfJTGFK #lungcancer
0
2
4
@drshieldsmd
Misty Dawn Shields
17 days
Proud mentor moment!! Three of my amazing @IUIntMed residents matched for Heme/Onc fellowship today at their top programs! Two top SCLC researchers staying at IU! ⚫️Dr. Paresh Kumar @PareshKumaaar, a stellar physician scientist in @TheShieldsLab who bridges the bench to
2
4
32
@IUCancerCenter
IU Simon Comprehensive Cancer Center
17 days
Gain insights from a new article published in @JTOonline by our trainees Tianhao Zhou, Olivia C. Terry, Katherine G. Minton, and the cancer center’s Nasser H. Hanna, MD, Misty D. Shields, MD, PhD, and colleagues. Learn more: https://t.co/MfwOkWyIuw.
0
3
6
@doclauravater
Laura Vater, MD, MPH
18 days
Each morning before clinic, I look at my list of patients for the day and pray for each person: For peace and presence during our time together, for insights into their care, for their wellbeing and healing, and for their families. Do you have rituals in your practice?
15
9
176
@drshieldsmd
Misty Dawn Shields
18 days
A beautiful #winter wonderland of #snow ❄️ #gratitude #worship #blessed
1
1
11
@EGFRResisters
EGFR Resisters
22 days
Small cell lung cancer has long needed faster progress & the science is finally shifting. @drshieldsmd is seeing new therapies & emerging approaches that offer more options, more precision & for some more time. What breakthroughs give you hope? #StoriesOfLungCancer #LCAM25
1
8
21
@StephenVLiu
Stephen V Liu, MD
23 days
Grateful for the friends and colleagues that have become a second family over the years
2
5
63
@BalazsHalmosMD
Balazs Halmos
23 days
Happiest Thanksgiving turkey and many positive trials, onc friends! #lcsm
2
7
45
@BRicciutiMD
Biagio Ricciuti, MD, PhD
25 days
The #MaTOS conference remains one of the most practical and meaningful forums we have, grounded in real cases and shared learning. Grateful to the Chairs for the invite & for the opportunity to learn together @EddieSantosMD @LuisRaezMD @ReckampK @christine_lovly @DanaFarber
1
4
20